{ "company_number": "09420886", "name": "Renascience Pharma Limited", "url": "/company/09420886", "status": "Active", "is_active": true, "company_type": "Private Limited Company", "incorporated_on": "2015-02-04", "dissolved_on": null, "sic_codes": [ { "code": "21100", "description": "Manufacture of basic pharmaceutical products", "section": "C", "section_name": "Manufacturing", "url": "/sic/21100" } ], "registered_address": { "id": 854817, "url": "/address/854817", "line1": "THE URBAN BUILDING SECOND FLOOR", "line2": "3-9 ALBERT STREET", "post_town": "SLOUGH", "county": "BERKSHIRE", "country": "UNITED KINGDOM", "postcode": "SL1 2BE" }, "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/09420886", "previous_names": [], "care_of": "", "po_box": "", "country_of_origin": "United Kingdom", "accounts": { "next_due": "2027-12-31", "last_made_up": "2026-03-31", "category": "FULL", "filings": [ { "url": "/company/09420886/accounts/2025-03-31", "pdf_url": "/company/09420886/accounts/2025-03-31.pdf", "made_up_date": "2025-03-31", "period_start": "2024-03-01", "period_end": "2025-03-31", "entity_name": "Renascience Pharma Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": "902272.00", "current_assets": "1819281.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": null, "total_assets_less_current_liabilities": null, "net_assets_liabilities": "959782.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "200.00", "turnover": "3684407.00", "other_operating_income": null, "cost_sales": "1323735.00", "gross_profit_loss": "2360672.00", "administrative_expenses": "573226.00", "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": "1787446.00", "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": "1310984.00", "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-March2026.zip" }, { "url": "/company/09420886/accounts/2024-02-29", "pdf_url": "/company/09420886/accounts/2024-02-29.pdf", "made_up_date": "2024-02-29", "period_start": "2024-02-29", "period_end": "2024-02-29", "entity_name": "Renascience Pharma Limited", "dormant": false, "average_employees": "0.00", "tangible_fixed_assets": "6444.00", "debtors": "120003.00", "cash_bank_in_hand": "347858.00", "current_assets": "578539.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "243287.00", "total_assets_less_current_liabilities": "249731.00", "net_assets_liabilities": "248798.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "100.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2024.zip" }, { "url": "/company/09420886/accounts/2023-02-28", "pdf_url": "/company/09420886/accounts/2023-02-28.pdf", "made_up_date": "2023-02-28", "period_start": "2023-02-28", "period_end": "2023-02-28", "entity_name": "Renascience Pharma Limited", "dormant": false, "average_employees": "2.00", "tangible_fixed_assets": "9813.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "386312.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "299770.00", "total_assets_less_current_liabilities": "309583.00", "net_assets_liabilities": "308289.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "308289.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-October2023.zip" }, { "url": "/company/09420886/accounts/2022-02-28", "pdf_url": "/company/09420886/accounts/2022-02-28.pdf", "made_up_date": "2022-02-28", "period_start": "2022-02-28", "period_end": "2022-02-28", "entity_name": "Renascience Pharma Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": "18094.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "117089.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "60238.00", "total_assets_less_current_liabilities": "78332.00", "net_assets_liabilities": "77098.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "77098.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2022.zip" }, { "url": "/company/09420886/accounts/2021-02-28", "pdf_url": "/company/09420886/accounts/2021-02-28.pdf", "made_up_date": "2021-02-28", "period_start": "2021-02-28", "period_end": "2021-02-28", "entity_name": "Renascience Pharma Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": "12876.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "151945.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "82579.00", "total_assets_less_current_liabilities": "95455.00", "net_assets_liabilities": "93467.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "93467.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-January2022.zip" }, { "url": "/company/09420886/accounts/2020-02-28", "pdf_url": "/company/09420886/accounts/2020-02-28.pdf", "made_up_date": "2020-02-28", "period_start": "2020-02-28", "period_end": "2020-02-28", "entity_name": "Renascience Pharma Limited", "dormant": false, "average_employees": "4.00", "tangible_fixed_assets": "17994.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "128449.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "66179.00", "total_assets_less_current_liabilities": "84173.00", "net_assets_liabilities": "83229.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "83229.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-February2021.zip" }, { "url": "/company/09420886/accounts/2019-02-28", "pdf_url": "/company/09420886/accounts/2019-02-28.pdf", "made_up_date": "2019-02-28", "period_start": "2019-02-28", "period_end": "2019-02-28", "entity_name": "Renascience Pharma Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": null, "debtors": null, "cash_bank_in_hand": null, "current_assets": null, "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-45717.00", "total_assets_less_current_liabilities": "-36103.00", "net_assets_liabilities": "-37019.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": null, "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2019.zip" }, { "url": "/company/09420886/accounts/2018-02-28", "pdf_url": "/company/09420886/accounts/2018-02-28.pdf", "made_up_date": "2018-02-28", "period_start": "2018-02-28", "period_end": "2018-02-28", "entity_name": "Renascience Pharma Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "11357.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "79778.00", "creditors_due_within_one_year": null, "creditors_due_after_one_year": null, "net_current_assets_liabilities": "3321.00", "total_assets_less_current_liabilities": "8036.00", "net_assets_liabilities": "7236.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "7236.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2018.zip" }, { "url": "/company/09420886/accounts/2017-02-28", "pdf_url": "/company/09420886/accounts/2017-02-28.pdf", "made_up_date": "2017-02-28", "period_start": "2017-02-28", "period_end": "2017-02-28", "entity_name": "Renascience Pharma Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "12252.00", "debtors": null, "cash_bank_in_hand": null, "current_assets": "127038.00", "creditors_due_within_one_year": "97053.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "29985.00", "total_assets_less_current_liabilities": "42237.00", "net_assets_liabilities": "41067.00", "called_up_share_capital": null, "profit_loss_account_reserve": null, "shareholder_funds": "41067.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2017.zip" }, { "url": "/company/09420886/accounts/2016-02-28", "pdf_url": "/company/09420886/accounts/2016-02-28.pdf", "made_up_date": "2016-02-28", "period_start": "2016-02-28", "period_end": "2016-02-28", "entity_name": "Renascience Pharma Limited", "dormant": false, "average_employees": null, "tangible_fixed_assets": "13783.00", "debtors": "100.00", "cash_bank_in_hand": "8941.00", "current_assets": "9041.00", "creditors_due_within_one_year": "25420.00", "creditors_due_after_one_year": null, "net_current_assets_liabilities": "-16379.00", "total_assets_less_current_liabilities": "-2596.00", "net_assets_liabilities": "-2596.00", "called_up_share_capital": "100.00", "profit_loss_account_reserve": "-2696.00", "shareholder_funds": "-2596.00", "turnover": null, "other_operating_income": null, "cost_sales": null, "gross_profit_loss": null, "administrative_expenses": null, "raw_materials_consumables": null, "staff_costs": null, "depreciation_written_off": null, "other_operating_charges": null, "operating_profit_loss": null, "profit_before_tax": null, "tax_on_profit": null, "profit_loss_for_period": null, "file_type": "html", "parse_error": "", "source_zip": "Accounts_Monthly_Data-November2016.zip" } ], "pdf_only_filings": [ { "made_up_date": "2026-03-31", "filing_date": "2026-05-11", "form_type": "AA", "description": "accounts-with-accounts-type-full", "paper_filed": true, "pdf_url": "/company/09420886/accounts/2026-03-31.pdf", "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/09420886/filing-history/MzUyMDEwNTA3MWFkaXF6a2N4/document?format=pdf&download=0" } ], "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/09420886/filing-history" }, "confirmation_statement": { "next_due": "2027-04-16", "last_made_up": "2026-04-02" }, "officers": [], "psc": [ { "name": "Mr Haziq Patel", "kind": "individual-person-with-significant-control", "person_url": "/person/1874877", "controlling_company_url": null, "natures_of_control": [ "significant-influence-or-control" ], "notified_on": "2017-02-04", "ceased_on": "2025-04-02", "nationality": "British", "country_of_residence": "United Kingdom", "source": "snapshot" }, { "name": "Mr Peter Mollison", "kind": "individual-person-with-significant-control", "person_url": "/person/3967881", "controlling_company_url": null, "natures_of_control": [ "significant-influence-or-control" ], "notified_on": "2017-02-04", "ceased_on": "2025-04-02", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Mr Ka Yan Che", "kind": "individual-person-with-significant-control", "person_url": "/person/2553685", "controlling_company_url": null, "natures_of_control": [ "significant-influence-or-control" ], "notified_on": "2017-02-04", "ceased_on": "2025-04-02", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Mr Mobeen Akhtar", "kind": "individual-person-with-significant-control", "person_url": "/person/3422810", "controlling_company_url": null, "natures_of_control": [ "significant-influence-or-control" ], "notified_on": "2017-02-04", "ceased_on": "2025-04-02", "nationality": "British", "country_of_residence": "England", "source": "snapshot" }, { "name": "Lupin Healthcare (Uk) Limited", "kind": "corporate-entity-person-with-significant-control", "person_url": null, "controlling_company_url": "/company/06925119", "natures_of_control": [ "ownership-of-shares-75-to-100-percent", "voting-rights-75-to-100-percent" ], "notified_on": "2025-04-02", "ceased_on": null, "nationality": "", "country_of_residence": "", "source": "snapshot" } ], "external_links": [], "provenance": { "source": "snapshot", "first_seen_at": "2026-07-05T12:35:35.811816+00:00", "last_seen_snapshot": "2026-09-01", "retrieved_at": "2026-09-27T03:24:04.087973+00:00" }, "licence": "Open Government Licence v3.0", "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/", "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House." }